Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle.
Fertil Steril
; 69(4): 665-9, 1998 Apr.
Article
en En
| MEDLINE
| ID: mdl-9548155
ABSTRACT
OBJECTIVE:
To investigate, in patients who previously had a suboptimal ovarian stimulation cycle, the benefit of starting ovarian stimulation before the onset of menses.DESIGN:
Prospective, randomized, controlled study.SETTING:
A tertiary referral center for infertility treatment. PATIENT(S) Forty patients undergoing IVF or GIFT from whom only 3-6 oocytes were retrieved in their last cycle. INTERVENTION(S) Recombinant human FSH was administered before the onset of the menstrual period (experimental group) or in the early follicular phase after the onset of menses (control group). MAIN OUTCOME MEASURE(S) The number of oocytes retrieved. RESULT(S) Patients in the experimental group were ready for oocyte retrieval on menstrual cycle day 11 instead of cycle day 14. The number of oocytes retrieved was not significantly different between the two groups. CONCLUSION(S) Poor responders do not benefit from commencing recombinant human FSH therapy in the luteal phase.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Oocitos
/
Fertilización In Vitro
/
Hormona Folículo Estimulante
/
Infertilidad Femenina
/
Fase Luteínica
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Fertil Steril
Año:
1998
Tipo del documento:
Article
País de afiliación:
Australia